What’s On
(TUE)
Yeung Kin Man Academic Building
Tsinghua University,
China
(WED)
Yeung Kin Man Academic Building
The Hong Kong Polytechnic University
9:00 AM – 6:00 PM
Inno2 – Multi-Function Room 2, 2/F, Building 17W, Phase 3, HKSTP, 17 Science Park West Avenue, Shatin, N.T.
An Introduction to Undergraduate Programmes in Department of Biomedical Sciences (JS1805, JS1806, JS1807)
10:30 AM – 11:15 AM
YEUNG LT-18
Becoming a Biomedical Scientist – Exploring our Clinical Laboratories and Research Facilities (JS1805, JS1806, JS1807)
11:30 AM – 12:15 PM
Gather at Purple Zone, 4/F, YEUNG
An Introduction to Undergraduate Programmes in Department of Biomedical Sciences (JS1805, JS1806, JS1807)
14:30 PM – 15:15 PM
YEUNG LT-18
Becoming a Biomedical Scientist – Exploring our Clinical Laboratories and Research Facilities (JS1805, JS1806, JS1807)
15:30 PM – 16:15 PM
Gather at Purple Zone, 4/F, YEUNG
CityUHK Campus
An Introduction to Undergraduate Programmes in Department of Biomedical Sciences (JS1805, JS1806, JS1807)
10:30 AM – 11:15 AM
YEUNG LT-18
Becoming a Biomedical Scientist – Exploring our Clinical Laboratories and Research Facilities (JS1805, JS1806, JS1807)
11:30 AM – 12:15 PM
Gather at Purple Zone, 4/F, YEUNG
An Introduction to Undergraduate Programmes in Department of Biomedical Sciences (JS1805, JS1806, JS1807)
14:30 PM – 15:15 PM
YEUNG LT-18
Becoming a Biomedical Scientist – Exploring our Clinical Laboratories and Research Facilities (JS1805, JS1806, JS1807)
15:30 PM – 16:15 PM
Gather at Purple Zone, 4/F, YEUNG
Biomedical Sciences Joins CityUHK’s Record HK$60M Interdisciplinary Research Success
18 March 2025
CityUHK has achieved new milestones in research, with 10 outstanding scholars receiving funding from the Research Grants Council’s (RGC) Collaborative Research Fund (CRF), totaling over HK$60 million—marking a record high for the University. These 10 interdisciplinary and inter-institutional research initiatives cover various cutting-edge academic fields, including biomedical sciences and neuroscience, robotics and automation, environmental science and resource recovery, artificial intelligence and big data, and materials science and energy, fully demonstrating CityUHK’s strengths in research and innovation.
learn more
Prof. Rebecca Chin Awarded HMRF Grant for Breast Cancer Research
17 March 2025
Prof. Rebecca Chin receives an HMRF grant of HK$1.49M for research on RNA-based therapy and organoid technology to improve breast cancer treatment.RNA Therapeutics to Overcome Chemoresistance in Breast Cancer” (Ref: 12231836).
learn more
Prof. Liang Zhang Awarded ITF Grant for CAR-NK Cell Therapy Research
14 March 2025
Congratulations to Prof. Liang Zhang, who has recently been awarded an Innovation and Technology Fund (ITF) grant of HK$1,392,650 for his research project titled “Development of Human Peripheral CAR-NK Cells to Treat Autoimmune Juvenile Dermatomyositis: Technology Innovation and Mechanistic Study.”
learn more
Research team led by Prof. Mengsu (Michael) Yang develops an innovative bio-detection platform for cancer early screening and disease monitoring
10 March 2025
Cancer continues to be a leading cause of mortality worldwide, highlighting the urgent need to develop more advanced, efficient, and early detection methods. Addressing this critical need, City University of Hong Kong (CityUHK) is leading a groundbreaking research project aimed at developing an innovative technology platform for early detection of cancer and personalised treatment. The project aims specifically to enhance the detection of circulating tumor cells (CTCs), paving the way for significant advancements in cancer diagnosis and care. This is one of the first batch of projects that has secured funding by the HKSAR Government's RAISe+ Scheme (the Research, Academic and Industry Sectors One-plus Scheme).
learn more
Congratulations to Prof. Zongli Zheng on Receiving the Shenzhen Medical Research Fund
20 January 2025
Congratulations to Prof. Zongli Zheng on receiving the Shenzhen Medical Research Fund (深圳市醫學研究專項資金) recently. His research group is interested in genomic medicine and biotechnology innovation to advance the understanding, diagnosis, and treatment of diseases. He previously invented the AMP technology, which was initially implemented in top U.S. hospitals and has since been adopted globally in molecular diagnostic tests for targeted cancer therapies.
learn more
BMS Retreat 2025
19 January 2025
The Department of Biomedical Sciences (BMS) successfully concluded its annual BMS Retreat on 7 January 2025, a day dedicated to fostering collaboration, inspiring discussions, and strengthening the bond among faculty members and staff.
learn moreOur
Programmes
Recent
Research
Papers
Automatic high-throughput and non-invasive selection of sperm at the biochemical level
Y. Mu, X. Zhou, L. Li, X. Liu, X. Wen, L. Zhang, B. Yan, W. Zhang, K. Dong, H. Hu, Y. Liao, Z. Ye, A. Deng, Y. Wang, Z. Mao, M. Yang, X. Xiao (2025). Automatic high-throughput and non-invasive selection of sperm at the biochemical level. Med, 5(6):603-621.e7.
Extracellular Vesicle Preparation and Analysis: A State-of-the-Art Review
Z. Wang, X. Zhou, Q. Kong, H. He, J. Sun, W. Qiu, L. Zhang, M. Yang (2024). Extracellular Vesicle Preparation and Analysis: A State-of-the-Art Review. Advanced Science, 11:2401069.
m6A RNA methyltransferase METTL16 induces Cr(VI) carcinogenesis and lung cancer development through glutamine biosynthesis and GLUL expression
Y.-X. Xie, L. Wang, Z.-H. Zhou, W.-J. Liu, W. Wang, J.-H. Yang, M.-L. He, J.-G. Qiu & B.-H. Jiang (2024). m6A RNA methyltransferase METTL16 induces Cr(VI) carcinogenesis and lung cancer development through glutamine biosynthesis and GLUL expression. Journal of Hazardous Materials, 480:136093.
GCclassifier: An R package for the prediction of molecular subtypes of gastric cancer
J. Li, L. He, X. Zhang, X. Li, L. Wang, Z. Zhua, K. Song & X. Wang (2024). GCclassifier: An R package for the prediction of molecular subtypes of gastric cancer. Computational and Structural Biotechnology Journal, 23:752–758.
Daily oral administration of probiotics engineered to constantly secrete short-chain fatty acids effectively prevents myocardial injury from subsequent ischaemic heart disease
Q. H. Pham, T. V. A. Bui, W.-S. Sim, K. H. Lim, C. O. K. Law, W. Tan, R. Y. Kim, K. T. Chow*, H.-J. Park*, K. Ban* & T. C. K. Lau* (2024). Daily oral administration of probiotics engineered to constantly secrete short-chain fatty acids effectively prevents myocardial injury from subsequent ischaemic heart disease. Cardiovascular Research, cvae128.
aaaaatitlehere
* (bbbbbyear). aaaaatitlehere. cccccnameofjournalhere, dddddvolumehere(eeeeeissuehere):fffffpagenumberhere.
BMS Research
Thoughts
Innovative Bio-Detection for Early Cancer Diagnosis
Next-gen Platform for Screening & Monitoring
Engineered Probiotics Shield Against Heart Stroke
New Research Breakthrough
Quantifying the Deadly Impact of Air Pollutants
New Research Underscores Need for Coordinated Pollution Control
Get in
Touch
Department of
Biomedical Sciences
City University of
Hong Kong
1A-101, 1/F, Block 1,
To Yuen Building,
31 To Yuen Street,
Kowloon Tong,
Hong Kong
24 March 2025